CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCloskey, P.
Right arrow Articles by Liu, E. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCloskey, P.
Right arrow Articles by Liu, E. T.

Cell Growth & Differentiation, Vol 5, Issue 10 1105-1117, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells

P McCloskey, J Pierce, RA Koski, B Varnum and ET Liu
Department of Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill 27599.

axl is a transforming receptor tyrosine kinase isolated from DNA of patients with chronic myelogenous leukemia. Association of axl expression with myelogenous leukemias and its expression in primitive hematopoietic cells suggests a role for axl in myeloid biology. To study the cellular function of axl, we constructed a chimeric receptor tyrosine kinase composed of the extracellular and transmembrane domains of the EGF receptor and the cytoplasmic domain of axl; this chimera was named EAK for EGFR-Axl-Kinase. The EAK chimeric receptor was expressed in the mouse myeloid progenitor cell line 32D, which is dependent on interleukin 3 (IL-3) for proliferation and survival. Treatment of the 32D-EAK cells with EGF stimulated the tyrosine phosphorylation of the axl kinase domain and enabled proliferation through EGF rather than IL-3. Thus, axl can effectively couple with mitogenic signaling pathways intrinsic to 32D myeloid cells. Assay of proteins phosphorylated in response to different cytokine treatments showed that IL-3 and EGF exposure produced unique profiles in the 32D-EAK cells. Furthermore, Jak-2 is phosphorylated only in response to IL-3 treatment in these cells. This suggests that IL-3 receptor and axl transduce mitogenic signals through separate pathways. In addition, exposure of cells expressing the chimeric receptor to EGF for 19 days converted the cells to factor-independent growth, a phenomenon not seen with other receptor tyrosine kinases. Generation of this transformed phenotype is absolutely dependent on axl activation by foster ligand. The tyrosine phosphorylation level of the axl kinase domain in the factor-independent subclones is 40-fold greater than the factor-dependent cells. The association of a unique axl phosphorylation level with the factor-independent phenotype suggests that there is a threshold phosphorylation level of the axl kinase for transformation. The fact that activation of the axl receptor leads to transformation of 32D cells suggests that axl can play a role in leukemic conversion of myeloid cells, either through inappropriate expression or improper activation.


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
J. D. Paccez, K. Duncan, A. Vava, R. G. Correa, T. A. Libermann, M. I. Parker, and L. F. Zerbini
Inactivation of GSK3{beta} and activation of NF-{kappa}B pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma
Mol. Biol. Cell, March 1, 2015; 26(5): 821 - 831.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Krause, C. Pfeiffer, S. Strube, A. Alsadeq, H. Fedders, C. Vokuhl, S. Loges, J. Waizenegger, I. Ben-Batalla, G. Cario, et al.
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS)
Blood, January 29, 2015; 125(5): 820 - 830.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
A. S. Meyer, M. A. Miller, F. B. Gertler, and D. A. Lauffenburger
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Sci. Signal., August 6, 2013; 6(287): ra66 - ra66.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. D.M. Collett, A. P. Sage, J. P. Kirton, M. Y. Alexander, A. P. Gilmore, and A. E. Canfield
Axl/Phosphatidylinositol 3-Kinase Signaling Inhibits Mineral Deposition by Vascular Smooth Muscle Cells
Circ. Res., March 2, 2007; 100(4): 502 - 509.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yang, S. Qu, M. Perez-Tores, A. Sawai, N. Rosen, D. B. Solit, and C. L. Arteaga
Association with HSP90 Inhibits Cbl-Mediated Down-regulation of Mutant Epidermal Growth Factor Receptors.
Cancer Res., July 15, 2006; 66(14): 6990 - 6997.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. Holland, M. J. Powell, C. Franci, E. W. Chan, A. M. Friera, R. E. Atchison, J. McLaughlin, S. E. Swift, E. S. Pali, G. Yam, et al.
Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation
Cancer Res., October 15, 2005; 65(20): 9294 - 9303.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. E. Stearns, M. Wang, Y. Hu, and F.U. Garcia
Interleukin-10 Activation of the Interleukin-10E1 Pathway and Tissue Inhibitor of Metalloproteinase-1 Expression Is Enhanced by Proteasome Inhibitors in Primary Prostate Tumor Lines
Mol. Cancer Res., July 1, 2003; 1(9): 631 - 642.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. L. Guttridge, J. C. Luft, T. L. Dawson, E. Kozlowska, N. P. Mahajan, B. Varnum, and H. S. Earp
Mer Receptor Tyrosine Kinase Signaling: PREVENTION OF APOPTOSIS AND ALTERATION OF CYTOSKELETAL ARCHITECTURE WITHOUT STIMULATION OR PROLIFERATION
J. Biol. Chem., July 5, 2002; 277(27): 24057 - 24066.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. A. Callus and B. Mathey-Prevot
Interleukin-3-Induced Activation of the JAK/STAT Pathway Is Prolonged by Proteasome Inhibitors
Blood, May 1, 1998; 91(9): 3182 - 3192.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. McCloskey, Y.-W. Fridell, E. Attar, J. Villa, Y. Jin, B. Varnum, and E. T. Liu
GAS6 Mediates Adhesion of Cells Expressing the Receptor Tyrosine Kinase Axl
J. Biol. Chem., September 12, 1997; 272(37): 23285 - 23291.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.